In particular, compounds 10 and 11 (Scheme 13) showed strong P-gp inhibition, outperforming R(+)-verapamil and tariquidar in the colorectal carcinoma MDR DLD1-TxR cells. Here, PGP is linked to colorectal carcinoma.